ZIM
ELGX

Zacks Investment Management’s Endologix Inc ELGX Stock Holding History

Zacks Investment Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,961
Closed -$108K – 621
2019
Q2 		$108K Buy
+14,961
New +$102K ﹤0.01% 510

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Zacks Investment Management's ELGX Position: Q3 2019 in Review

Zacks Investment Management sold out of Endologix Inc (ELGX) in Q3 2019, closing a stake of 14,961 shares — an estimated $108K sold.

Zacks Investment Management first reported a position in ELGX in Q2 2019 and held it in 1 quarter. The position peaked at $108K in Q2 2019. 63 funds tracked by Wall St. Rank hold ELGX as of Q3 2019.

  • Zacks Investment Management reported no remaining Endologix Inc position as of Q3 2019 after selling out during the quarter.
  • Zacks Investment Management sold 14,961 Endologix Inc shares in Q3 2019, an estimated $108K.
  • Zacks Investment Management first reported a position in Endologix Inc in Q2 2019 and held it in 1 quarter.
  • Zacks Investment Management's Endologix Inc position peaked at $108K in Q2 2019.
  • 63 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2019.

Based on Zacks Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.